Targeting Tumor Microenvironment, Boston: Pre-meeting notes 2

In the run up to the Targeting the Tumor Microenvironment meeting, taking place in Boston, this October, there are some great resources available to you to download free of charge from the website resources page.

Targeting Tumor Microenvironment, Boston: Pre-meeting notes 1

"Targeting the Tumor Microenvironment" meeting will take place in Boston in October and will be looking at how to achieve tumor delivery, tackle drug resistance and improve clinical efficacy.

Focus on Tumour immunology & immunotherapy from Nature Reviews Cancer and Nature Reviews Immunology

The tumour microenvironment is an important aspect of cancer biology that contributes to tumour initiation, tumour progression and responses to therapy. Cells and molecules of the immune system are a fundamental component of the tumour microenvironment. 

Biogen Idec walking away from its cancer franchise. What (new drugs) may be lost in shakeup.

Yesterday's big announcement by Biogen Idec to disinvest itself from its cancer franchise (and shut down San Diego site) got me thinking what else was in the pipeline and preclinical programs which may (probably) never see the light of a doctor's office.  Was there an Avastin-like blockbuster sitting on a shelf somewhere?  Hopefully, some of the programs will be licensed off to someone with deep pockets or belief in it.  It can happen here in San Diego and some star molecules may emerge! [...][...]